A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease

NCT01702714 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Project Team decision

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Interventions

DRUG: RO5083945
DRUG: carboplatin
DRUG: cisplatin
DRUG: gemcitabine
DRUG: paclitaxel

Sponsor

Hoffmann-La Roche